Submission Details
| 510(k) Number | K231840 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 22, 2023 |
| Decision Date | July 20, 2023 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K231840 is an FDA 510(k) clearance for the CastleLoc-S Posterior Cervical Fixation System, a Posterior Cervical Screw System (Class II — Special Controls, product code NKG), submitted by L & K Biomed Co., Ltd. (Yongin-Si, KR). The FDA issued a Cleared decision on July 20, 2023, 28 days after receiving the submission on June 22, 2023. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3075.
| 510(k) Number | K231840 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 22, 2023 |
| Decision Date | July 20, 2023 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | NKG — Posterior Cervical Screw System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3075 |
| Definition | Posterior Cervical Screw Systems Are Intended For Use In Fusion Procedures Of The Cervical Spine And/or Craniocervical Junction And/or Cervicothoracic Junction For: 1) Spinal Fractures And Dislocations; 2) Deformities; 3) Instabilities; 4) Failed Previous Fusions; 5) Tumors; 6) Inflammatory Disorders; 7) Spinal Degeneration, 8) Facet Degeneration With Instability; And 9) Reconstruction Following Decompression To Treat Radiculopathy And/or Myelopathy. These Systems Are Also Intended To Stabilize The Spine In The Absence Of Fusion For A Limited Time Period In Patients With Tumors Involving The Cervical Spine In Whom Life Expectancy Is Of Insufficient Duration To Permit Achievement Of Fusion. |